Cargando…
Untargeted Metabolomic Characterization of Glioblastoma Intra-Tumor Heterogeneity Using OrbiSIMS
[Image: see text] Glioblastoma (GBM) is an incurable brain cancer with a median survival of less than two years from diagnosis. The standard treatment of GBM is multimodality therapy comprising surgical resection, radiation, and chemotherapy. However, prognosis remains poor, and there is an urgent n...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100400/ https://www.ncbi.nlm.nih.gov/pubmed/36995369 http://dx.doi.org/10.1021/acs.analchem.2c05807 |
_version_ | 1785025270343794688 |
---|---|
author | He, Wenshi Edney, Max K. Paine, Simon M. L. Griffiths, Rian L. Scurr, David J. Rahman, Ruman Kim, Dong-Hyun |
author_facet | He, Wenshi Edney, Max K. Paine, Simon M. L. Griffiths, Rian L. Scurr, David J. Rahman, Ruman Kim, Dong-Hyun |
author_sort | He, Wenshi |
collection | PubMed |
description | [Image: see text] Glioblastoma (GBM) is an incurable brain cancer with a median survival of less than two years from diagnosis. The standard treatment of GBM is multimodality therapy comprising surgical resection, radiation, and chemotherapy. However, prognosis remains poor, and there is an urgent need for effective anticancer drugs. Since different regions of a single GBM contain multiple cancer subpopulations (“intra-tumor heterogeneity”), this likely accounts for therapy failure as certain cancer cells can escape from immune surveillance and therapeutic threats. Here, we present metabolomic data generated using the Orbitrap secondary ion mass spectrometry (OrbiSIMS) technique to investigate brain tumor metabolism within its highly heterogeneous tumor microenvironment. Our results demonstrate that an OrbiSIMS-based untargeted metabolomics method was able to discriminate morphologically distinct regions (viable, necrotic, and non-cancerous) within single tumors from formalin-fixed paraffin-embedded tissue archives. Specifically, cancer cells from necrotic regions were separated from viable GBM cells based on a set of metabolites including cytosine, phosphate, purine, xanthine, and 8-hydroxy-7-methylguanine. Moreover, we mapped ubiquitous metabolites across necrotic and viable regions into metabolic pathways, which allowed for the discovery of tryptophan metabolism that was likely essential for GBM cellular survival. In summary, this study first demonstrated the capability of OrbiSIMS for in situ investigation of GBM intra-tumor heterogeneity, and the acquired information can potentially help improve our understanding of cancer metabolism and develop new therapies that can effectively target multiple subpopulations within a tumor. |
format | Online Article Text |
id | pubmed-10100400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-101004002023-04-14 Untargeted Metabolomic Characterization of Glioblastoma Intra-Tumor Heterogeneity Using OrbiSIMS He, Wenshi Edney, Max K. Paine, Simon M. L. Griffiths, Rian L. Scurr, David J. Rahman, Ruman Kim, Dong-Hyun Anal Chem [Image: see text] Glioblastoma (GBM) is an incurable brain cancer with a median survival of less than two years from diagnosis. The standard treatment of GBM is multimodality therapy comprising surgical resection, radiation, and chemotherapy. However, prognosis remains poor, and there is an urgent need for effective anticancer drugs. Since different regions of a single GBM contain multiple cancer subpopulations (“intra-tumor heterogeneity”), this likely accounts for therapy failure as certain cancer cells can escape from immune surveillance and therapeutic threats. Here, we present metabolomic data generated using the Orbitrap secondary ion mass spectrometry (OrbiSIMS) technique to investigate brain tumor metabolism within its highly heterogeneous tumor microenvironment. Our results demonstrate that an OrbiSIMS-based untargeted metabolomics method was able to discriminate morphologically distinct regions (viable, necrotic, and non-cancerous) within single tumors from formalin-fixed paraffin-embedded tissue archives. Specifically, cancer cells from necrotic regions were separated from viable GBM cells based on a set of metabolites including cytosine, phosphate, purine, xanthine, and 8-hydroxy-7-methylguanine. Moreover, we mapped ubiquitous metabolites across necrotic and viable regions into metabolic pathways, which allowed for the discovery of tryptophan metabolism that was likely essential for GBM cellular survival. In summary, this study first demonstrated the capability of OrbiSIMS for in situ investigation of GBM intra-tumor heterogeneity, and the acquired information can potentially help improve our understanding of cancer metabolism and develop new therapies that can effectively target multiple subpopulations within a tumor. American Chemical Society 2023-03-30 /pmc/articles/PMC10100400/ /pubmed/36995369 http://dx.doi.org/10.1021/acs.analchem.2c05807 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | He, Wenshi Edney, Max K. Paine, Simon M. L. Griffiths, Rian L. Scurr, David J. Rahman, Ruman Kim, Dong-Hyun Untargeted Metabolomic Characterization of Glioblastoma Intra-Tumor Heterogeneity Using OrbiSIMS |
title | Untargeted
Metabolomic Characterization of Glioblastoma
Intra-Tumor Heterogeneity Using OrbiSIMS |
title_full | Untargeted
Metabolomic Characterization of Glioblastoma
Intra-Tumor Heterogeneity Using OrbiSIMS |
title_fullStr | Untargeted
Metabolomic Characterization of Glioblastoma
Intra-Tumor Heterogeneity Using OrbiSIMS |
title_full_unstemmed | Untargeted
Metabolomic Characterization of Glioblastoma
Intra-Tumor Heterogeneity Using OrbiSIMS |
title_short | Untargeted
Metabolomic Characterization of Glioblastoma
Intra-Tumor Heterogeneity Using OrbiSIMS |
title_sort | untargeted
metabolomic characterization of glioblastoma
intra-tumor heterogeneity using orbisims |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100400/ https://www.ncbi.nlm.nih.gov/pubmed/36995369 http://dx.doi.org/10.1021/acs.analchem.2c05807 |
work_keys_str_mv | AT hewenshi untargetedmetabolomiccharacterizationofglioblastomaintratumorheterogeneityusingorbisims AT edneymaxk untargetedmetabolomiccharacterizationofglioblastomaintratumorheterogeneityusingorbisims AT painesimonml untargetedmetabolomiccharacterizationofglioblastomaintratumorheterogeneityusingorbisims AT griffithsrianl untargetedmetabolomiccharacterizationofglioblastomaintratumorheterogeneityusingorbisims AT scurrdavidj untargetedmetabolomiccharacterizationofglioblastomaintratumorheterogeneityusingorbisims AT rahmanruman untargetedmetabolomiccharacterizationofglioblastomaintratumorheterogeneityusingorbisims AT kimdonghyun untargetedmetabolomiccharacterizationofglioblastomaintratumorheterogeneityusingorbisims |